Calvin Colosimo
|Subscribers
About
Dianabol 8R,9S,10S,13S,14S,17S-17-hydroxy-10,13
Below is a practical "road‑map" for taking a **generic drug** (already approved in one indication or still in early‑phase development) and turning it into a new therapy for another disease. It’s written as a step‑by‑step guide that you can follow in your own lab or clinic, with concrete examples of what to do at each stage.
---
## 1️⃣ Define the New Indication
| Step | What You Do | Example |
|------|-------------|---------|
| **Identify unmet need** | Search for diseases where current treatments are inadequate (high mortality, poor quality‑of‑life, no curative option). | Chronic pain with limited opioid alternatives. |
| **Literature & data mining** | Use PubMed, clinicaltrials.gov, FDA/EMA databases to see if the drug has been studied in that context. | A drug originally approved for hypertension has shown anti‑inflammatory effects in pre‑clinical models of arthritis. |
| **Stakeholder input** | Talk with clinicians, patient advocacy groups, and payers. | Patients with fibromyalgia demand non‑addictive therapies. |
Once a plausible indication is identified, the next step is to justify that the drug’s pharmacology will be effective for this new use.
---
## 2. Demonstrating Pharmacologic Rationale
| **Aspect** | **What to Show** | **Typical Evidence** |
|------------|------------------|----------------------|
| **Mechanism of Action (MOA)** | How the drug acts at a molecular target relevant to the disease | Receptor binding assays, signaling pathway studies |
| **Target Validation** | The target is expressed and functionally important in the affected tissue | Gene‑expression data, knockdown/knockout experiments |
| **Preclinical Activity** | In vitro or animal models of the disease show efficacy | Cell‑based phenotypic screens, rodent disease models |
| **PK/PD Relationship** | Exposure levels needed for target engagement are achievable and safe | Dose‑response curves, therapeutic window analysis |
---
## 2. How to Document Evidence
| Section | Content | Key Elements to Include |
|---------|---------|------------------------|
| **Background** | Brief disease description; unmet medical need | Epidemiology, current therapy gaps |
| **Therapeutic Rationale** | Why the drug works in this indication | Mechanism of action, pathway relevance |
| **Pre‑clinical Evidence** | Data supporting efficacy and safety | In vitro assays, animal models, toxicology |
| **Clinical Evidence (if any)** | Early phase trials or compassionate use data | Phase I/II results, PK/PD, safety profile |
| **Comparative Advantage** | How it compares to existing options | Efficacy, safety, dosing convenience |
| **Regulatory Status** | Current approval stage in other indications | IND status, clinical trial phases |
| **Risk Assessment** | Potential challenges and mitigation strategies | Immunogenicity, off‑target effects |
This framework should be adapted based on the specific disease area and therapeutic modality.
---
### 3. How to Build a Robust Case for the Company
| Step | Action | Key Deliverables |
|------|--------|------------------|
| **a) Define the Therapeutic Opportunity** | Identify unmet medical need; quantify market size (patient population, pricing potential). | Market research report; patient‑care pathway analysis. |
| **b) Map the Product to the Need** | Explain how the therapy addresses the problem (mechanism, efficacy, safety profile). | Comparative effectiveness diagram; early clinical data snapshot. |
| **c) Highlight Competitive Advantage** | Compare with existing therapies: efficacy, dosing, safety, cost. | SWOT matrix; head‑to‑head table. |
| **d) Provide Scientific Validation** | Present preclinical/early clinical evidence, patents, regulatory status. | Data slides (PK/PD curves, efficacy graphs), patent summary. |
| **e) Demonstrate Market Viability** | Show reimbursement landscape, pricing strategy, projected sales. | Market sizing chart; payer coverage map. |
---
## 3. How to Build a Powerful Slide Deck
1. **Keep it Concise**
- *Rule of 10*: 10 slides max (or 15 for deeper dives).
- One key idea per slide.
2. **Structure the Story**
- **Title/Agenda** – what’s coming next?
- **Problem Statement** – why does this matter?
- **Solution Overview** – your product/service in a nutshell.
- **Benefits & Evidence** – data, case studies.
- **Market Opportunity** – size and growth.
- **Business Model** – how you make money.
- **Go‑to‑Market Plan** – strategy to reach customers.
- **Team** – who’s executing this vision?
- **Ask/Next Steps** – what do you want from the audience?
### 2. Keep It Simple
- **One Idea per Slide**: Avoid cluttering slides with multiple points.
- **Visuals Over Text**: Use charts, infographics, icons—people remember images better.
- **Consistent Design**: Same fonts, colors, and layout throughout.
- **Legible Font Size**: Minimum 18‑pt for body text; headings larger.
### 3. Tell a Story
A pitch isn’t just facts—it’s a narrative:
1. **Hook** – Start with something memorable (a statistic, a short anecdote, or a striking image).
2. **Problem** – Show why this issue matters.
3. **Solution** – Explain how you solve it and why it works.
4. **Market & Business Model** – Who will buy? How will you make money?
5. **Traction** – Provide evidence of progress (users, revenue, partnerships).
6. **Team** – Highlight relevant skills and experience.
7. **Ask** – State what you need (funding, partnership) and the benefits to the audience.
The story should flow logically; each slide supports a narrative step. When rehearsed, your presentation will feel natural and persuasive.
---
## 3. Practical Design Tips
| What | Why it Works | How to Do It |
|------|--------------|-------------|
| **Use a clean template** | Reduces distractions. | Choose one of PowerPoint’s default themes or download a minimalistic slide master from sites like SlidesCarnival, Envato Elements, or Microsoft Office templates. |
| **Keep text concise (6‑words‑per‑line rule)** | Helps viewers read quickly. | Aim for 2–3 lines per slide. Use bullet points sparingly. |
| **High‑contrast color palette** | Enhances readability & brand consistency. | Dark text on light background or vice versa; use brand colors if applicable. |
| **Large, legible fonts (≥24pt)** | Ensures readability from a distance. | Use sans‑serif fonts like Arial, Calibri, or Open Sans. |
| **Use icons & visuals instead of words** | Improves engagement & retention. | Replace "increase" with an upward arrow icon; use pictograms for processes. |
| **Consistent slide layout** | Gives a professional, cohesive look. | Keep title position, bullet points, and image placement uniform. |
| **Avoid clutter – use white space** | Enhances clarity and focus. | Leave margins, reduce unnecessary lines or text. |
| **Include subtle animation/transitions (optional)** | Adds polish without distraction. | Fade in bullets one by one if presenting live. |
---
## 3. Applying the Guidelines to the Sample Text
| Original Sentence | Suggested Rephrase & Design Tips |
|-------------------|---------------------------------|
| **"The process of generating an accurate and meaningful report is often a long, complicated task."** | • **Rephrase:** "Creating an accurate, insightful report can be lengthy and complex."
• **Design:** Use concise bullet points; bold key words ("accurate," "insightful"). |
| **"We must carefully collect relevant data, clean it up, perform analyses, interpret results, write conclusions, and finally package everything into a presentable format."** | • **Rephrase:** "Collect, cleanse, analyze, interpret, report, and package data."
• **Design:** Create a horizontal flowchart or numbered list to visually separate steps. |
| **"If we do not follow a systematic approach, errors can creep in unnoticed, leading to faulty insights that might misguide stakeholders."** | • **Rephrase:** "Without structure, mistakes slip through, compromising insight integrity."
• **Design:** Use a warning icon or red highlight for critical points. |
| **"Therefore, it is imperative that we implement rigorous data‑quality checks and audit trails at each stage of the pipeline to maintain trustworthiness."** | • **Rephrase:** "Rigorous quality controls and audits are essential for reliable insights."
• **Design:** Incorporate a checklist graphic or a flow diagram with checkpoints. |
---
### Quick Tips for Refining Your Slides
| Tip | What it Means | Example |
|-----|---------------|---------|
| **Cut the fluff** | Keep only what drives the message forward. | Remove "In summary" paragraphs that repeat earlier points. |
| **Show, don’t tell** | Use visuals to convey complex ideas faster than text. | Replace a 4‑sentence explanation of an algorithm with a flowchart. |
| **Use the rule of three** | Limit each slide to 3–5 bullet points or key facts. | "Why this matters" → *Impact*, *Opportunity*, *Risk*. |
| **Align with your narrative** | Each slide should link logically to the next. | End slide on "Challenges" before moving to "Solutions". |
| **Proofread for clarity** | Avoid jargon unless defined; keep sentences concise. | "This method improves throughput by 30%" vs. "This approach optimizes the data pipeline performance." |
---
## How to Use This Cheat‑Sheet
1. **Start with a skeleton outline** of your presentation.
2. **Insert one slide at a time**, applying the relevant section from this cheat‑sheet.
3. **Review the narrative flow** – make sure each slide leads naturally into the next.
4. **Apply the formatting and design guidelines** for consistency.
5. **Proofread** with the "Write" section in mind, keeping sentences short and clear.
---
### Quick Reference (one‑page version)
| Section | Key Points |
|---------|------------|
| Hook | Engaging intro + problem statement |
| Vision | What you’re solving; why it matters |
| Problem | Specific pain points & evidence |
| Solution | Features + benefits; demo link |
| Impact | Metrics, testimonials, ROI |
| Call to Action | Next steps, contact info |
---
**Tip:** Use the "Write" section as a checklist when drafting each slide.
- **Hook**: 1‑2 sentences.
- **Vision**: 3‑4 bullets.
- **Problem**: 2‑3 pain points + stats.
- **Solution**: 5 key features + benefit per feature.
- **Impact**: 1 metric, 1 testimonial.
- **CTA**: Clear action & contact.
Happy pitching!");">Metandienone
Psychiatry related information on : Metandienone ]");">Metandienone
High impact information on : Metandienone ]");">Metandienone
Chemical compound and disease context of : Metandienone ]");">Metandienone
Biological context of : Metandienone ]");">Metandienone
Anatomical context of : Metandienone ]");">Metandienone
Associations of : Metandienone ]");">Metandienone with other chemical compounds
Gene context of : Metandienone ]");">Metandienone
References]
